⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19558962 | 0.77 | — | — | |
| SCHEMBL23073859 | 0.75 | — | — | |
| SCHEMBL19657864 | 0.75 | — | — | |
| SCHEMBL14440030 | 0.72 | — | — | |
| SCHEMBL18462205 | 0.72 | — | — | |
| SCHEMBL18462462 | 0.72 | — | — | |
| SCHEMBL18462463 | 0.72 | — | — | |
| SCHEMBL23177885 | 0.71 | PIK3CD (0.31) | — | |
| SCHEMBL23178018 | 0.71 | PIK3CD (0.31) | — | |
| SCHEMBL23177932 | 0.71 | PIK3CD (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210094983-A1 | MODIFIED PEPTIDES FOR USE IN TREATING NEURODEGENERATIVE DISORDERS | NEURO-BIO LTD. (GB) | 2021-04-01 | — | — | US | disclosed |